1. Home
  2. WSR vs TBPH Comparison

WSR vs TBPH Comparison

Compare WSR & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Whitestone REIT

WSR

Whitestone REIT

HOLD

Current Price

$19.03

Market Cap

973.9M

Sector

Real Estate

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$16.08

Market Cap

824.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WSR
TBPH
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
973.9M
824.9M
IPO Year
2002
2013

Fundamental Metrics

Financial Performance
Metric
WSR
TBPH
Price
$19.03
$16.08
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$19.00
$18.40
AVG Volume (30 Days)
436.5K
289.3K
Earning Date
05-01-2026
05-04-2026
Dividend Yield
3.01%
N/A
EPS Growth
31.94
279.13
EPS
0.08
N/A
Revenue
$160,859,000.00
$15,386,000.00
Revenue This Year
$2.77
$8.46
Revenue Next Year
$4.21
N/A
P/E Ratio
$237.66
N/A
Revenue Growth
4.26
N/A
52 Week Low
$11.43
$9.98
52 Week High
$19.02
$21.03

Technical Indicators

Market Signals
Indicator
WSR
TBPH
Relative Strength Index (RSI) 80.32 40.51
Support Level $18.90 $13.41
Resistance Level N/A $17.21
Average True Range (ATR) 0.02 0.34
MACD -0.06 -0.06
Stochastic Oscillator 93.75 4.84

Price Performance

Historical Comparison
WSR
TBPH

About WSR Whitestone REIT

Whitestone REIT is a real estate investment trust (REIT) that owns and operates commercial properties in culturally diverse metropolitan markets. The company's primary business objective is to increase shareholder value by acquiring, owning, and operating Community Centered Properties. Its property portfolio includes retail and mixed-use properties located in business-friendly locations in and around Austin, Scottsdale, Dallas, Houston, Phoenix, Arizona, and San Antonio. The properties are convenience-focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care (health and fitness), services (financial and logistics), education, and entertainment to the surrounding communities.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: